Royal Bank Of Canada Petros Pharmaceuticals, Inc. Transaction History

Royal Bank Of Canada

  • $471 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$0.68 - $1.49 $38 - $84
-57 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$1.33 - $4.09 $2,584 - $7,946
-1,943 Reduced 97.15%
57 $0
Q2 2021

Aug 16, 2021
BUY
$2.87 - $4.11 $5,740 - $8,220
2,000 New
2,000 $6,000

About Petros Pharmaceuticals, Inc.

PTPI Quotes by TradingView
  • Ticker PTPI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 20,708,000
  • Market Cap $5.38M
  • Description
  • Petros Pharmaceuticals, Inc., a pharmaceutical company, focuses on men's health therapeutics. The company engages in the commercialization and development of Stendra, an PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction (ED). It also develops and commercializes H100, a patented topical formulation candidate for th...
More about PTPI
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email